Jackson J B
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis.
Arch Pathol Lab Med. 1990 Mar;114(3):249-53.
Commercial enzyme immunoassays have recently been developed for the detection and quantitation of human immunodeficiency virus type 1 (HIV-1) viral proteins in blood and other body fluids of infected patients. At the same time, culture assays for HIV-1 have become more rapid, sensitive, and specific for HIV-1 isolation from the blood of infected patients. Both of these assays have clinical utility in the diagnosis, prognosis, and monitoring of HIV-1 infection in certain patients.
最近开发了商业酶免疫测定法，用于检测和定量感染患者血液及其他体液中的1型人类免疫缺陷病毒（HIV-1）病毒蛋白。与此同时，用于HIV-1的培养测定法在从感染患者血液中分离HIV-1方面变得更快、更灵敏且更具特异性。这两种测定法在某些患者的HIV-1感染诊断、预后评估和监测中都具有临床实用性。
